BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nat Rev Neurol 2014;10:386-95. [DOI: 10.1038/nrneurol.2014.97] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 12.9] [Reference Citation Analysis]
Number Citing Articles
1 Coleman DK, Long B, Koyfman A. Clinical Mimics: An Emergency Medicine-Focused Review of Syncope Mimics. J Emerg Med 2018;54:81-9. [PMID: 29110977 DOI: 10.1016/j.jemermed.2017.09.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
2 Barateau L, Pizza F, Plazzi G, Dauvilliers Y. 50th anniversary of the ESRS in 2022-JSR special issue. J Sleep Res 2022;:e13631. [PMID: 35624073 DOI: 10.1111/jsr.13631] [Reference Citation Analysis]
3 Hasegawa E, Maejima T, Yoshida T, Masseck OA, Herlitze S, Yoshioka M, Sakurai T, Mieda M. Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity. Proc Natl Acad Sci U S A 2017;114:E3526-35. [PMID: 28396432 DOI: 10.1073/pnas.1614552114] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 8.6] [Reference Citation Analysis]
4 Dauvilliers Y, Barateau L. Narcolepsy and Other Central Hypersomnias. Continuum (Minneap Minn) 2017;23:989-1004. [PMID: 28777172 DOI: 10.1212/CON.0000000000000492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zečević I. Cognitive-Behavioural Therapy for Type 1 Narcolepsy Comorbid With Sleep and Psychiatric Disturbances: A Case Report. Behav change. [DOI: 10.1017/bec.2022.4] [Reference Citation Analysis]
6 Malomouzh A, Ilyin V, Nikolsky E. Components of the GABAergic signaling in the peripheral cholinergic synapses of vertebrates: a review. Amino Acids 2019;51:1093-102. [PMID: 31236726 DOI: 10.1007/s00726-019-02754-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pizza F, Antelmi E, Vandi S, Meletti S, Erro R, Baumann CR, Bhatia KP, Dauvilliers Y, Edwards MJ, Iranzo A, Overeem S, Tinazzi M, Liguori R, Plazzi G. The distinguishing motor features of cataplexy: a study from video-recorded attacks. Sleep 2018;41. [DOI: 10.1093/sleep/zsy026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Peever J, Fuller PM. Neuroscience: A Distributed Neural Network Controls REM Sleep. Curr Biol 2016;26:R34-5. [PMID: 26766231 DOI: 10.1016/j.cub.2015.11.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
9 Bandaru SS, Khanday MA, Ibrahim N, Naganuma F, Vetrivelan R. Sleep-Wake Control by Melanin-Concentrating Hormone (MCH) Neurons: a Review of Recent Findings. Curr Neurol Neurosci Rep 2020;20:55. [PMID: 33006677 DOI: 10.1007/s11910-020-01075-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Panossian LA, Avidan AY. Sleep Disorders in Neurologic Practice: A Case-based Approach. Neurol Clin 2016;34:565-94. [PMID: 27445242 DOI: 10.1016/j.ncl.2016.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Burdakov D. Reactive and predictive homeostasis: Roles of orexin/hypocretin neurons. Neuropharmacology 2019;154:61-7. [PMID: 30347195 DOI: 10.1016/j.neuropharm.2018.10.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
12 Siegel JM. Rapid Eye Movement Sleep. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 78-95.e6. [DOI: 10.1016/b978-0-323-24288-2.00008-8] [Cited by in Crossref: 13] [Article Influence: 2.6] [Reference Citation Analysis]
13 Berhe DF, Gebre AK, Assefa BT. Orexins role in neurodegenerative diseases: From pathogenesis to treatment. Pharmacol Biochem Behav 2020;194:172929. [PMID: 32315694 DOI: 10.1016/j.pbb.2020.172929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Szabadi E. GHB for cataplexy: Possible mode of action. J Psychopharmacol 2015;29:744-9. [DOI: 10.1177/0269881115573807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
15 Wozniak DR, Quinnell TG. Unmet needs of patients with narcolepsy: perspectives on emerging treatment options. Nat Sci Sleep 2015;7:51-61. [PMID: 26045680 DOI: 10.2147/NSS.S56077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
16 Sun Y, Liu M. Hypothalamic MCH Neuron Activity Dynamics during Cataplexy of Narcolepsy. eNeuro 2020;7:ENEURO. [PMID: 32303567 DOI: 10.1523/ENEURO.0017-20.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Dauvilliers Y, Barateau L, Lopez R, Rassu AL, Chenini S, Beziat S, Jaussent I. Narcolepsy Severity Scale: a reliable tool assessing symptom severity and consequences. Sleep 2020;43:zsaa009. [DOI: 10.1093/sleep/zsaa009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
18 Naganuma F, Bandaru SS, Absi G, Mahoney CE, Scammell TE, Vetrivelan R. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy. Neurobiol Dis 2018;120:12-20. [PMID: 30149182 DOI: 10.1016/j.nbd.2018.08.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
19 Pintwala S, Peever J. Circuit mechanisms of sleepiness and cataplexy in narcolepsy. Current Opinion in Neurobiology 2017;44:50-8. [DOI: 10.1016/j.conb.2017.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
20 Matos N, Gaig C, Santamaria J, Iranzo A. Tricks to rapidly terminate episodes of cataplexy in narcolepsy. Sleep Medicine 2016;20:129-30. [DOI: 10.1016/j.sleep.2015.09.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Seong MJ, Choi SJ, Hong SB, Joo EY. Test-Retest Reliability of Multiple Sleep Latency Test in Diagnosis of Narcolepsy. J Sleep Med 2020;17:175-80. [DOI: 10.13078/jsm.200033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Lopez R, Doukkali A, Barateau L, Evangelista E, Chenini S, Jaussent I, Dauvilliers Y. Test–Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence. Sleep 2017;40. [DOI: 10.1093/sleep/zsx164] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 9.6] [Reference Citation Analysis]
23 Barateau L, Pizza F, Lopez R, Antelmi E, Plazzi G, Dauvilliers Y. Persistence of deep-tendon reflexes during partial cataplexy. Sleep Medicine 2018;45:80-2. [DOI: 10.1016/j.sleep.2017.12.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Romigi A, Caccamo M, Vitrani G, Testa F, Nicoletta C, Sarno AC, Di Gioia B, Centonze D. A false alarm of narcolepsy: obstructive sleep apnea masquerading as narcolepsy and vice-versa: two further controversial cases. Sleep Breath 2021;25:367-70. [PMID: 32297143 DOI: 10.1007/s11325-020-02070-9] [Reference Citation Analysis]
25 Dye TJ, Jain SV, Kothare SV. Central Hypersomnia. Semin Pediatr Neurol 2015;22:93-104. [PMID: 26072339 DOI: 10.1016/j.spen.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
26 Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol 2019;161:353-67. [PMID: 31307613 DOI: 10.1016/B978-0-444-64142-7.00060-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
27 Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Med Rev 2019;43:23-36. [PMID: 30503715 DOI: 10.1016/j.smrv.2018.09.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
28 Kim LJ, Coelho FM, Hirotsu C, Araujo P, Bittencourt L, Tufik S, Andersen ML. Frequencies and Associations of Narcolepsy-Related Symptoms: A Cross-Sectional Study. J Clin Sleep Med 2015;11:1377-84. [PMID: 26235160 DOI: 10.5664/jcsm.5268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
29 Kim H, Cho JW. Narcolepsy, How do We Manage it? J Sleep Med 2020;17:1-10. [DOI: 10.13078/jsm.200006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
30 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
31 Sun Y, Blanco-Centurion C, Bendell E, Vidal-Ortiz A, Luo S, Liu M. Activity dynamics of amygdala GABAergic neurons during cataplexy of narcolepsy. Elife 2019;8:e48311. [PMID: 31411561 DOI: 10.7554/eLife.48311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Baek JH, Jeon J, Lee S. Narcolepsy Patient Presenting as Drop Attack without Emotional Triggering and Subjective Sleepiness. Sleep Med Res 2016;7:74-7. [DOI: 10.17241/smr.2016.00094] [Reference Citation Analysis]
33 Lind A, Freyhult E, Ramelius A, Olsson T, Arnheim-Dahlström L, Lamb F, Khademi M, Ambati A, Maeurer M, Lima Bomfim I, Fink K, Fex M, Törn C, Elding Larsson H, Lernmark Å. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls. Viral Immunol 2017;30:590-600. [PMID: 28796576 DOI: 10.1089/vim.2017.0066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
34 Peever J, Fuller PM. The Biology of REM Sleep. Current Biology 2017;27:R1237-48. [DOI: 10.1016/j.cub.2017.10.026] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 20.6] [Reference Citation Analysis]
35 Huang B, Qian Z, Wang Z, Zhang J, Chen K, Xu T, Wang J, Cechetto DF, Zhao Z, Wu H. Fluctuation of primary motor cortex excitability during cataplexy in narcolepsy. Ann Clin Transl Neurol 2019;6:210-21. [PMID: 30847354 DOI: 10.1002/acn3.670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Dauvilliers Y, Beziat S, Pesenti C, Lopez R, Barateau L, Carlander B, Luca G, Tafti M, Morin CM, Billiard M, Jaussent I. Measurement of narcolepsy symptoms: The Narcolepsy Severity Scale. Neurology 2017;88:1358-65. [PMID: 28258080 DOI: 10.1212/WNL.0000000000003787] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
37 Fraigne JJ, Grace KP, Horner RL, Peever J. Mechanisms of REM sleep in health and disease: . Current Opinion in Pulmonary Medicine 2014;20:527-32. [DOI: 10.1097/mcp.0000000000000103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Emsellem HA, Thorpy MJ, Lammers GJ, Shapiro CM, Mayer G, Plazzi G, Chen D, Carter LP, Villa KF, Lee L, Menno D, Black J, Dauvilliers Y. Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy. Sleep Medicine 2020;67:128-36. [DOI: 10.1016/j.sleep.2019.11.1250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
39 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
40 Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Sleep 2017;40. [PMID: 28364477 DOI: 10.1093/sleep/zsw010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
41 Barateau L, Liblau R, Peyron C, Dauvilliers Y. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. CNS Drugs 2017;31:821-34. [DOI: 10.1007/s40263-017-0464-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
42 Vaudano AE, Pizza F, Talami F, Plazzi G, Meletti S. The neuronal network of laughing in young patients with untreated narcolepsy. Neurology 2019:10. [PMID: 30635496 DOI: 10.1212/WNL.0000000000006853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
43 Horner RL, Peever JH. Brain Circuitry Controlling Sleep and Wakefulness. Continuum (Minneap Minn) 2017;23:955-72. [PMID: 28777170 DOI: 10.1212/CON.0000000000000495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chen HH, Tsai LK, Liao KY, Wu TC, Huang YH, Huang YC, Chang SW, Wang PY, Tsao YP, Chen SL. Muscle-restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down-regulation of myogenin at the neuromuscular junction. J Cachexia Sarcopenia Muscle 2018;9:771-85. [PMID: 29608040 DOI: 10.1002/jcsm.12299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
45 Ouyang H, Han F, Zhou ZC, Zheng QW, Wang YY, Zhang J. Relationship between T-cell receptor α gene polymorphisms and symptomatic differences in patients with narcolepsy type 1. Chin Med J (Engl) 2019;132:1796-801. [PMID: 31343434 DOI: 10.1097/CM9.0000000000000348] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Julkunen I, Partinen M. Neuroimmunology: Disease mechanisms in narcolepsy remain elusive. Nat Rev Neurol 2014;10:616-7. [PMID: 25311588 DOI: 10.1038/nrneurol.2014.191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
47 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
48 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
49 Fam DJ, Shammi P, Mainprize TG, Murray BJ. Dramatic Cataplexy Improvement Following Right Parietal Surgery. J Clin Sleep Med 2015;11:829-30. [PMID: 25902819 DOI: 10.5664/jcsm.4860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology. Front Neurol 2015;6:123. [PMID: 26074874 DOI: 10.3389/fneur.2015.00123] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
51 Pensato U, Pizza F, Plazzi G. Myasthenic or cataplectic facies? Ice pack test response in paediatric type 1 narcolepsy. Sleep Med 2021;87:20-1. [PMID: 34508983 DOI: 10.1016/j.sleep.2021.06.045] [Reference Citation Analysis]
52 Meskill GJ, Kallweit U, Zarycranski D, Caussé C, Finance O, Ligneau X, Davis CW. Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. [DOI: 10.1080/21678707.2021.2022472] [Reference Citation Analysis]
53 Torontali ZA, Fraigne JJ, Sanghera P, Horner R, Peever J. The Sublaterodorsal Tegmental Nucleus Functions to Couple Brain State and Motor Activity during REM Sleep and Wakefulness. Curr Biol 2019;29:3803-3813.e5. [PMID: 31679942 DOI: 10.1016/j.cub.2019.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Wändell P, Fredrikson S, Carlsson AC, Li X, Sundquist J, Sundquist K. Narcolepsy among first- and second-generation immigrants in Sweden: A study of the total population. Acta Neurol Scand 2022. [PMID: 35543223 DOI: 10.1111/ane.13633] [Reference Citation Analysis]
55 Juvodden HT, Viken MK, Nordstrand SEH, Viste R, Westlye LT, Thorsby PM, Lie BA, Knudsen-heier S. HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives. Sleep 2020;43:zsz239. [DOI: 10.1093/sleep/zsz239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
56 Trotti LM. Central Disorders of Hypersomnolence. Continuum (Minneap Minn) 2020;26:890-907. [PMID: 32756227 DOI: 10.1212/CON.0000000000000883] [Reference Citation Analysis]
57 Peleg-Raibstein D, Burdakov D. Do orexin/hypocretin neurons signal stress or reward? Peptides 2021;145:170629. [PMID: 34416308 DOI: 10.1016/j.peptides.2021.170629] [Reference Citation Analysis]
58 Martin T, Dauvilliers Y, Koumar OC, Bouet V, Freret T, Besnard S, Dauphin F, Bessot N. Dual orexin receptor antagonist induces changes in core body temperature in rats after exercise. Sci Rep 2019;9:18432. [PMID: 31804545 DOI: 10.1038/s41598-019-54826-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Thompson PD, Kimber TE. Brainstem lesions and gait. Handb Clin Neurol 2018;159:359-66. [PMID: 30482327 DOI: 10.1016/B978-0-444-63916-5.00023-9] [Reference Citation Analysis]
60 Monaca C, Franco P, Philip P, Dauvilliers Y. French consensus. Type 1 and type 2 Narcolepsy: Investigations and follow-up. Revue Neurologique 2017;173:25-31. [DOI: 10.1016/j.neurol.2016.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
61 Meletti S, Vaudano AE, Pizza F, Ruggieri A, Vandi S, Teggi A, Franceschini C, Benuzzi F, Nichelli PF, Plazzi G. The Brain Correlates of Laugh and Cataplexy in Childhood Narcolepsy. J Neurosci 2015;35:11583-94. [PMID: 26290235 DOI: 10.1523/JNEUROSCI.0840-15.2015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 5.9] [Reference Citation Analysis]
62 Dauvilliers Y, Shapiro C, Mayer G, Lammers GJ, Emsellem H, Plazzi G, Chen D, Carter LP, Lee L, Black J, Thorpy MJ. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial. CNS Drugs 2020;34:773-84. [PMID: 32588401 DOI: 10.1007/s40263-020-00744-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 de Biase S, Nilo A, Gigli GL, Valente M. Investigational therapies for the treatment of narcolepsy. Expert Opin Investig Drugs 2017;26:953-63. [PMID: 28726523 DOI: 10.1080/13543784.2017.1356819] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
64 Barateau L, Lopez R, Dauvilliers Y. Treatment Options for Narcolepsy. CNS Drugs 2016;30:369-79. [PMID: 27155860 DOI: 10.1007/s40263-016-0337-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
65 Juvodden HT, Alnæs D, Lund MJ, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Hypocretin-deficient narcolepsy patients have abnormal brain activation during humor processing. Sleep 2019;42:zsz082. [DOI: 10.1093/sleep/zsz082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
66 Almeneessier AS, Alballa NS, Alsalman BH, Aleissi S, Olaish AH, BaHammam AS. A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients. Nat Sci Sleep 2019;11:231-9. [PMID: 31695532 DOI: 10.2147/NSS.S229105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
67 Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y, Lehmann S. From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid. Sci Rep 2016;6:25162. [PMID: 27165941 DOI: 10.1038/srep25162] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
68 Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. French consensus. Management of patients with hypersomnia: Which strategy? Revue Neurologique 2017;173:8-18. [DOI: 10.1016/j.neurol.2016.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
69 Lima FCB, do Nascimento Junior EB, Teixeira SS, Coelho FM, Oliveira GDP. Thinking outside the box: cataplexy without narcolepsy. Sleep Med 2019;61:118-21. [PMID: 31427075 DOI: 10.1016/j.sleep.2019.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Equihua-Benítez AC, Equihua-Benítez JA, Guzmán-Vásquez K, Prospero-García O, Drucker-Colín R. Orexin cell transplant reduces behavioral arrest severity in narcoleptic mice. Brain Res 2020;1745:146951. [PMID: 32531224 DOI: 10.1016/j.brainres.2020.146951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Roth T, Dauvilliers Y, Guinta D, Alvarez-Horine S, Dynin E, Black J. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy. J Sleep Res 2017;26:407-14. [PMID: 27807903 DOI: 10.1111/jsr.12468] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
72 Barateau L, Lopez R, Dauvilliers Y. Management of Narcolepsy. Curr Treat Options Neurol 2016;18. [DOI: 10.1007/s11940-016-0429-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
73 Torterolo P, Castro-zaballa S, Cavelli M, Velasquez N, Brando V, Falconi A, Chase MH, Migliaro ER. Heart rate variability during carbachol-induced REM sleep and cataplexy. Behavioural Brain Research 2015;291:72-9. [DOI: 10.1016/j.bbr.2015.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
74 Cavaliere C, Longarzo M, Fogel S, Engström M, Soddu A. Neuroimaging of Narcolepsy and Primary Hypersomnias. Neuroscientist 2020;26:310-27. [PMID: 32111133 DOI: 10.1177/1073858420905829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
76 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
77 Pintwala SK, Peever J. Brain Circuits Underlying Narcolepsy. Neuroscientist 2021;:10738584211052263. [PMID: 34704497 DOI: 10.1177/10738584211052263] [Reference Citation Analysis]
78 Pillen S, Pizza F, Dhondt K, Scammell TE, Overeem S. Cataplexy and Its Mimics: Clinical Recognition and Management. Curr Treat Options Neurol 2017;19:23. [PMID: 28478511 DOI: 10.1007/s11940-017-0459-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
79 Pellitteri G, Dolso P, Valente M, Gigli GL. Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report. Nat Sci Sleep 2020;12:1237-40. [PMID: 33408544 DOI: 10.2147/NSS.S286358] [Reference Citation Analysis]
80 Hu B, Yang N, Qiao QC, Hu ZA, Zhang J. Roles of the orexin system in central motor control. Neurosci Biobehav Rev 2015;49:43-54. [PMID: 25511388 DOI: 10.1016/j.neubiorev.2014.12.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
81 Huang B, Xu T, Wang Z, Chen K, Zhang J, Zhao Z, Zhuang J, Wu H. The clinical characteristics of cataplectic attack in narcolepsy type 1. Sleep Med 2021;77:261-9. [PMID: 31607435 DOI: 10.1016/j.sleep.2019.03.015] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
82 Akpa B, Lee K. Update on Novel Medications to Treat Narcolepsy. Curr Sleep Medicine Rep 2020;6:189-97. [DOI: 10.1007/s40675-020-00178-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Susta M, Nemcova V, Bizik G, Sonka K. Emotion stimulus processing in narcolepsy with cataplexy. J Sleep Res 2017;26:30-7. [DOI: 10.1111/jsr.12444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
84 Snow MB, Fraigne JJ, Thibault-Messier G, Chuen VL, Thomasian A, Horner RL, Peever J. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy. J Neurosci 2017;37:4007-22. [PMID: 28209737 DOI: 10.1523/JNEUROSCI.4070-15.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
85 Torterolo P, Castro-Zaballa S, Cavelli M, Chase MH, Falconi A. Neocortical 40 Hz oscillations during carbachol-induced rapid eye movement sleep and cataplexy. Eur J Neurosci 2016;43:580-9. [PMID: 26670051 DOI: 10.1111/ejn.13151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
86 Thorpy MJ. Recently Approved and Upcoming Treatments for Narcolepsy. CNS Drugs 2020;34:9-27. [PMID: 31953791 DOI: 10.1007/s40263-019-00689-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
87 Swick TJ. Treatment paradigms for cataplexy in narcolepsy: past, present, and future. Nat Sci Sleep 2015;7:159-69. [PMID: 26715865 DOI: 10.2147/NSS.S92140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
88 Maitre M, Klein C, Mensah-Nyagan AG. Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain. Med Res Rev 2016;36:363-88. [PMID: 26739481 DOI: 10.1002/med.21382] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
89 Trotti LM, Saini P, Crosson B, Meltzer CC, Rye DB, Nye JA. Regional brain metabolism differentiates narcolepsy type 1 and idiopathic hypersomnia. Sleep 2021:zsab050. [PMID: 33693888 DOI: 10.1093/sleep/zsab050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Scherrer KS, Relly C, Hackenberg A, Berger C, Paioni P. Case report: narcolepsy type 1 in an adolescent with HIV infection-coincidence or potential trigger? Medicine (Baltimore) 2018;97:e11490. [PMID: 30045272 DOI: 10.1097/MD.0000000000011490] [Reference Citation Analysis]
91 Rogers AA, Aiani LM, Blanpain LT, Yuxian S, Moore R, Willie JT. Deep brain stimulation of hypothalamus for narcolepsy-cataplexy in mice. Brain Stimul 2020;13:1305-16. [PMID: 32320748 DOI: 10.1016/j.brs.2020.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Santifort KM, Ives EJ, Fenn J, Raimondi F, Lourinho F, Mandigers PJJ, Bergknut N. Suspected acquired narcolepsy in 8 dogs. J Vet Intern Med 2021;35:1448-54. [PMID: 33960533 DOI: 10.1111/jvim.16116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Burdakov D. How orexin signals bias action: Hypothalamic and accumbal circuits. Brain Res 2020;1731:145943. [PMID: 30205111 DOI: 10.1016/j.brainres.2018.09.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]